Related Experiment Video
Updated: Aug 3, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene
D Figarella-Branger1, J Pouget, R Bernard
1Service d'anatomie pathologique et de neuropathologie, Département de génétique médicale, Campus Hospitalier et Universitaire de la Timone, Marseille, France. Dominique.Figarella-Branger@medecine.univ-mrs.fr
Abstract:
The authors report a 71-year-old woman with limb-girdle muscular dystrophy (LGMD) associated with an R27Q mutation in the CAV3 gene. Immunohistochemistry showed a >90% reduction of caveolin-3 on the sarcolemma by western blot, and anti-dysferlin immunoreactivity was reduced. This case emphasizes that an R27Q missense mutation in the CAV3 gene can lead to various clinical phenotypes including hyperCKemia, rippling muscle disease, distal myopathy, and LGMD1C.
Insights
A rare R27Q mutation in the CAV3 gene can cause limb-girdle muscular dystrophy (LGMD) and other muscle disorders. This genetic mutation significantly reduces caveolin-3 protein, impacting muscle membrane integrity.
Area of Science:
- Genetics
- Molecular Biology
- Neuromuscular Disorders
Background:
- Limb-girdle muscular dystrophy (LGMD) encompasses a group of inherited muscle-weakening diseases.
- Mutations in the CAV3 gene, encoding caveolin-3, are known to cause certain muscular dystrophies.
- Caveolin-3 is crucial for sarcolemmal structure and function in muscle cells.
Observation:
- A 71-year-old woman presented with symptoms consistent with muscular dystrophy.
- Genetic analysis revealed an R27Q missense mutation in the CAV3 gene.
- Immunohistochemistry demonstrated a significant reduction (>90%) of sarcolemmal caveolin-3 and decreased anti-dysferlin immunoreactivity.
Findings:
- The R27Q CAV3 mutation is associated with a marked deficiency of caveolin-3 protein.
- Reduced caveolin-3 levels correlate with altered muscle membrane protein expression, including dysferlin.
- This specific mutation can manifest in diverse clinical phenotypes.
Implications:
- The R27Q CAV3 mutation can lead to a spectrum of muscle disorders, including LGMD1C, distal myopathy, and rippling muscle disease.
- Understanding this mutation's impact is vital for accurate diagnosis and potential therapeutic strategies in muscular dystrophy.
- This case highlights the complex relationship between CAV3 genotype and the resulting clinical presentation in muscular dystrophies.
More Related Videos
06:52Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cross-bridge Cycle
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Alterations in Muscle Tone lll